The US FDA has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer healthcare business, Opella.

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile dysfunction ((ED)) drug, Cialis. Read more here.

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical ...

Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...

Opella reaches study milestone for Cialis Paris1, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its ...

Browne, MD. In this video, Brendan M. Browne, MD, discusses which patients may be best suited to undergo HoLEP for benign prostatic hyperplasia (BPH). Browne is an assistant professor of urology at ...

Cialis (tadalafil) is a popular medication used to treat erectile dysfunction (ED) and the symptoms of benign prostatic hyperplasia (BPH). Understanding the correct dosage is essential to achieving ...

The approval was based on results from a 24-week Phase III study of Gemtesa versus placebo in around 1,100 men with OAB symptoms receiving pharmacologic therapy for BPH. All co-primary end points ...

"We are now in the golden era of BPH/BPO for both diagnostics and therapeutics," says Wayne Kuang, MD. In this video, Wayne Kuang, MD, shares his thoughts on what advances in benign prostatic ...

When taken with Cialis, alpha-blockers can cause a drop in blood pressure. These medications are frequently prescribed to manage high blood pressure, benign prostatic hyperplasia (enlarged ...